Cargando…
Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
BACKGROUND: A small proportion of patients with clinical parkinsonism have normal transporter-single photon emission computed tomography (DaTSPECT) which is commonly defined as scans without evidence of dopaminergic deficits (SWEDD). A better understanding of SWEDD can improve the current therapeuti...
Autores principales: | Nabizadeh, Fardin, KamaliZonouzi, Sara, Noori, Maryam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632530/ https://www.ncbi.nlm.nih.gov/pubmed/37953806 http://dx.doi.org/10.1016/j.ibneur.2023.10.001 |
Ejemplares similares
-
Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD)
por: Suwijn, Sven R., et al.
Publicado: (2020) -
Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson’s disease: Analysis of the PPMI data
por: Lee, Jeong Won, et al.
Publicado: (2021) -
Structural connectivity profile of scans without evidence of dopaminergic deficit (SWEDD) patients compared to normal controls and Parkinson’s disease patients
por: Kim, Mansu, et al.
Publicado: (2016) -
Association of autonomic symptoms with cerebrospinal fluid biomarkers in Parkinson disease and scans without evidence of dopaminergic deficit
por: Yu, Zhenwei, et al.
Publicado: (2021) -
Frontotemporal Lobe Degeneration as Origin of Scans Without Evidence of Dopaminergic Deficit
por: Menéndez-González, Manuel, et al.
Publicado: (2018)